Wells Fargo’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
Wells Fargo's WGS Position: Q2 2026 in Review
Wells Fargo reduced its GeneDx Holdings (WGS) stake by 3.8% in Q2 2026, selling an estimated $66K and leaving 29,138 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #3606.
Wells Fargo first reported a position in WGS in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.58M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- Wells Fargo held 29,138 shares of GeneDx Holdings worth $2M as of Q2 2026.
- Wells Fargo sold 1,162 GeneDx Holdings shares in Q2 2026, an estimated $66K.
- GeneDx Holdings made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3606 holding.
- Wells Fargo first reported a position in GeneDx Holdings in Q1 2021 and has held it in 22 quarters since.
- Wells Fargo's GeneDx Holdings position peaked at $5.58M in Q4 2025.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.